Narcolepsy Type 2 research hub

A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 2

This study is looking into a new medication called ALKS 2680 for people with Narcolepsy Type 2. We want to see if it's safe and helps improve sleepiness. Some people will get the new medicine, and others a dummy pill, to compare the results.